Interview: Ric Schumacher CEO, Pressure Bioscience (PBIO)
Our favorite interview to date, and there have been dozens. Filmed November of 2021, and the story has gotten to much better since.
https://vimeo.com/652106617
$PBIO,...
Dicerna (DRNA) up 78% Today. Being Acquired by Novo Nordisk (NVO) for $38.00.
We shoot and we score. Up 1,133% since adding to Watch List @ $3.00.
Our second $3.00 Watch List company getting acquired for over $1...
The Alkaline Water Company (WTER) Reports Record Second Quarter Revenue with 50% Year over...
$15.25 Million in Revenue is Best Quarter in Company History
SCOTTSDALE, Ariz., November 09, 2021–(BUSINESS WIRE)–The Alkaline Water Company Inc. (NASDAQ and CSE: WTER) (the...
Beachbody (BODY) Conference Call
"Make no mistake, as the single largest shareholder as well as CEO of Beachbody, but more so because I believe in the importance of...
Adding Beach Body (BODY) $3.90 to the Watch List.
This is Like Shooting Fish in the Barrell, but the Fish Shoot Back.
We’re not traders, but we are opportunistic with our entry point into...
Avicanna (AVCNF) $0.60 Conference Call.
8:30EST This Morning, Friday 11/12/21
Avicanna Inc. to Host Third Quarter 2021 Investor Conference Call.
TORONTO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or...
Nautilus (NLS) $8.50, Numbers Out. Time to go Bottom Fishing?
Adding Nautilus to the Watch List. Conference Call Transcript Below
New Street Targets at $15 per Share.
How often do you come across a Company reporting...
Peloton Plunges $9 Billion in Value, on a $805 Million Quarter!
Peloton just reported the $805 million for three months worth of business ended September. That's $9 million worth of fitness everyday. And the machines...
Revive Therapeutics (RVVTF, RVV.CN) in Discussions to Secure Supply of 5 Billion Bucillamine Tablets.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
Not wanting to be caught flat-footed upon potential approval, Revive is...
Cybin (CYBN) Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using...
October 26, 2021 07:30 AM Eastern Daylight Time
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics,...
Latest article
GeoVax (GOVX) Monkeypox (MPOX) PowerPoint.
In a recent press release, GeoVax shared progress on their MPOX Vaccine and published a PowerPoint related to the their planned upcoming MonkeyPox trial..
The...
Rick Rule Symposium – Conference Cheat Sheet
Natural Resource Investing Symposium - Presenter Guide
We've attended hundreds and hundreds of Investment Conferences (Barclay, JP Morgan, LD Micro, Piper Sandler, Roth, VRIC) since...
GeoVax (GOVX) Surges 256%, With 207 Million Shares Trading!
What an Entertaining Week!
..and it's only Thursday.
LIVE QUOTE
(MAY 18TH)
(MAY 21ST)
So Where Does That Leave us Today?
Yes, it was a pleasant surprise to see GeoVax...
